Neurogene Inc. Interest Expense
Neurogene Inc. (NGNE) reported Interest Expense of $3.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-10
- Neurogene Inc. interest expense for the quarter ending 2024-03-31 was $3.00K, a 50.00% increase year-over-year.
- Neurogene Inc. interest expense for the quarter ending 2023-03-31 was $2.00K.
- Neurogene Inc. interest expense for the quarter ending 2015-09-30 was $4.00K, a 100.00% increase year-over-year.
- Neurogene Inc. interest expense for the quarter ending 2015-06-30 was $5.00K, a 150.00% increase year-over-year.
- Neurogene Inc. interest expense for fiscal 2023 was $12.00K, a 500.00% increase from fiscal 2022.
- Neurogene Inc. interest expense for fiscal 2022 was $2.00K.
- Neurogene Inc. interest expense for fiscal 2019 was $1.00K, a 75.00% decline from fiscal 2018.
- Neurogene Inc. interest expense for fiscal 2018 was $4.00K, a 0.00% change from fiscal 2017.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed | Interest Expense 123 month |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-10 | ||||||||
| 2023-12-31 | $12.00K 10-K · filed 2024-03-18 | ||||||||
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-10 | ||||||||
| 2022-12-31 | $2.00K 10-K · filed 2024-03-18 | ||||||||
| 2019-12-31 | $1.00K 10-K · filed 2020-03-12 | ||||||||
| 2018-12-31 | $4.00K 10-K · filed 2020-03-12 | ||||||||
| 2017-12-31 | $4.00K 10-K · filed 2020-03-12 | ||||||||
| 2016-12-31 | $1.00K 10-K · filed 2019-03-07 | ||||||||
| 2015-09-30 | $4.00K 10-Q · filed 2015-11-10 | $9.00K derived: sum of 2 quarters · filed 2015-11-10 | $15.00K 10-Q · filed 2015-11-10 | $7.00K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2015-06-30 | $5.00K 10-Q · filed 2015-08-06 | $10.00K 10-Q · filed 2015-08-06 | $3.00K derived: sum of 3 quarters · filed 2017-03-09 | $5.00K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2015-03-31 | $6.00K 10-Q · filed 2015-05-12 | -$2.00K derived: sum of 2 quarters · filed 2017-03-09 | $0.00 derived: sum of 3 quarters · filed 2017-03-09 | $2.39K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2014-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$6.00K derived: sum of 2 quarters · filed 2017-03-09 | -$3.61K derived: sum of 3 quarters · filed 2017-03-09 | $451.00K 10-K · filed 2017-03-09 | $461.59K 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | $2.00K 10-Q · filed 2015-11-10 | $2.46K 10-Q · filed 2014-11-04 | $4.39K derived: sum of 2 quarters · filed 2015-11-10 | $459.00K 10-Q · filed 2015-11-10 | $458.65K 10-Q · filed 2014-11-04 | $496.06K derived: sum of 4 quarters · filed 2015-11-10 | |||
| 2014-06-30 | $2.00K 10-Q · filed 2015-08-06 | $456.00K 10-Q · filed 2015-08-06 | $456.20K 10-Q · filed 2014-08-11 | $494.06K derived: sum of 3 quarters · filed 2015-05-12 | $495.71K derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2014-03-31 | $454.00K 10-Q · filed 2015-05-12 | $453.81K 10-Q · filed 2014-05-13 | $491.68K derived: sum of 2 quarters · filed 2015-05-12 | $493.32K derived: sum of 3 quarters · filed 2015-05-12 | $495.09K derived: sum of 4 quarters · filed 2015-05-12 | $590.02K 10-Q · filed 2014-05-13 | |||
| 2013-12-31 | $37.68K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $39.32K derived: sum of 2 quarters · filed 2015-03-16 | $41.09K derived: sum of 3 quarters · filed 2015-03-16 | $42.92K 10-K · filed 2015-03-16 | |||||
| 2013-09-30 | $1.64K 10-Q · filed 2014-11-04 | $3.41K derived: sum of 2 quarters · filed 2014-11-04 | $5.25K 10-Q · filed 2014-11-04 | ||||||
| 2013-06-30 | $1.77K 10-Q · filed 2014-08-11 | $3.60K 10-Q · filed 2014-08-11 | |||||||
| 2013-03-31 | $1.83K 10-Q · filed 2014-05-13 | ||||||||
| 2012-12-31 | $9.47K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |